Clinical trial
Open-label Pilot Study of the Effects of Anakinra in Mucopolysaccharidosis (MPS) III
NCT04018755 is registered in ClinicalTrials.gov with Lynda E Polgreen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-label Pilot Study of the Effects of Anakinra in Mucopolysaccharidosis (MPS) III
- Lead sponsor
- Lynda E Polgreen
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 30, 2020
- Completion date
- March 8, 2023
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.